DaVita Inc. (DVA)

US — Healthcare Sector
Peers: SGRY  ACHC  ENSG  FSNUY  THC  HCA  USPH  AMED  OPCH  EHC  UHS  AMN  CYH 

Automate Your Wheel Strategy on DVA

With Tiblio's Option Bot, you can configure your own wheel strategy including DVA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol DVA
  • Rev/Share 161.3508
  • Book/Share 21.4639
  • PB -30.3608
  • Debt/Equity -33.0157
  • CurrentRatio 1.3935
  • ROIC 0.1125

 

  • MktCap 9836970000.0
  • FreeCF/Share 15.7929
  • PFCF 7.6361
  • PE 13.4195
  • Debt/Assets 0.6898
  • DivYield 0
  • ROE -25.9516

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Berkshire sells some DaVita shares, cuts stake to 45%
BRK-A, BRK-B, DVA
Published: February 13, 2025 by: Reuters
Sentiment: Negative

Berkshire Hathaway said on Thursday night it sold 203,091 shares of DaVita , reducing its stake in the kidney dialysis services provider to about 35.89 million shares, a 45% stake worth nearly $6.4 billion.

Read More
image for news Berkshire sells some DaVita shares, cuts stake to 45%
DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?
DVA
Published: February 12, 2025 by: Zacks Investment Research
Sentiment: Positive

Continued strength in RPT is likely to have boosted DaVita's top line in the fourth quarter despite supply challenges weighing on its performance.

Read More
image for news DVA Q4 Estimates Unchanged Before Earnings: How to Play the Stock?

About DaVita Inc. (DVA)

  • IPO Date 1995-10-31
  • Website https://www.davita.com
  • Industry Medical - Care Facilities
  • CEO Javier J. Rodriguez
  • Employees 76000

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.